Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Garfall AL, Maus MV, Hwang WT, Lacey SF, Mahnke YD, Melenhorst JJ, Zheng Z, Vogl DT, Cohen AD, Weiss BM, Dengel K, Kerr ND, Bagg A, Levine BL, June CH, Stadtmauer EA. N Engl J Med. 2015 Sep 10;373(11):1040-1047 | doi: 10.1056/NEJMoa1504542
Summary
NEJM report on sustained remission after treatment with investigational personalized cellular therapy in patient with multiple myeloma.
Read the Department of Communications news release.
